339 related articles for article (PubMed ID: 34819867)
1. Recent Research Progress (2015-2021) and Perspectives on the Pharmacological Effects and Mechanisms of Tanshinone IIA.
Zhong C; Lin Z; Ke L; Shi P; Li S; Huang L; Lin X; Yao H
Front Pharmacol; 2021; 12():778847. PubMed ID: 34819867
[TBL] [Abstract][Full Text] [Related]
2. Tanshinone I: Pharmacological activities, molecular mechanisms against diseases and future perspectives.
Ke L; Zhong C; Chen Z; Zheng Z; Li S; Chen B; Wu Q; Yao H
Phytomedicine; 2023 Feb; 110():154632. PubMed ID: 36608501
[TBL] [Abstract][Full Text] [Related]
3. Tanshinone IIA inhibited intermittent hypoxia induced neuronal injury through promoting autophagy via AMPK-mTOR signaling pathway.
Si J; Liu B; Qi K; Chen X; Li D; Yang S; Ji E
J Ethnopharmacol; 2023 Oct; 315():116677. PubMed ID: 37268259
[TBL] [Abstract][Full Text] [Related]
4. Tanshinone IIA regulates CCl
Li Q; Huang D; Liao W; Su X; Li J; Zhang J; Fang M; Liu Y
J Biochem Mol Toxicol; 2024 Feb; 38(2):e23648. PubMed ID: 38348705
[TBL] [Abstract][Full Text] [Related]
5. Potential pharmacological mechanisms of tanshinone IIA in the treatment of human neuroblastoma based on network pharmacological and molecular docking Technology.
Tang N; Wang Y; Miao J; Zhao Y; Cao Y; Sun W; Zhang J; Sui H; Li B
Front Pharmacol; 2024; 15():1363415. PubMed ID: 38533261
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological Activity and Mechanism of Tanshinone IIA in Related Diseases.
Guo R; Li L; Su J; Li S; Duncan SE; Liu Z; Fan G
Drug Des Devel Ther; 2020; 14():4735-4748. PubMed ID: 33192051
[No Abstract] [Full Text] [Related]
7. A comprehensive review of tanshinone IIA and its derivatives in fibrosis treatment.
Bi Z; Wang Y; Zhang W
Biomed Pharmacother; 2021 May; 137():111404. PubMed ID: 33761617
[TBL] [Abstract][Full Text] [Related]
8. Salvia miltiorrhiza and Tanshinone IIA reduce endothelial inflammation and atherosclerotic plaque formation through inhibiting COX-2.
Ma X; Zhang L; Gao F; Jia W; Li C
Biomed Pharmacother; 2023 Nov; 167():115501. PubMed ID: 37713995
[TBL] [Abstract][Full Text] [Related]
9. Tanshinone IIA suppresses lipopolysaccharide-induced neuroinflammatory responses through NF-κB/MAPKs signaling pathways in human U87 astrocytoma cells.
Jin H; Peng X; He Y; Ruganzu JB; Yang W
Brain Res Bull; 2020 Nov; 164():136-145. PubMed ID: 32860868
[TBL] [Abstract][Full Text] [Related]
10. Tanshinone IIA suppresses FcεRI-mediated mast cell signaling and anaphylaxis by activation of the Sirt1/LKB1/AMPK pathway.
Li X; Park SJ; Jin F; Deng Y; Yang JH; Chang JH; Kim DY; Kim JA; Lee YJ; Murakami M; Son KH; Chang HW
Biochem Pharmacol; 2018 Jun; 152():362-372. PubMed ID: 29674003
[TBL] [Abstract][Full Text] [Related]
11. Tanshinone IIA induces mitochondria dependent apoptosis in prostate cancer cells in association with an inhibition of phosphoinositide 3-kinase/AKT pathway.
Won SH; Lee HJ; Jeong SJ; Lee HJ; Lee EO; Jung DB; Shin JM; Kwon TR; Yun SM; Lee MH; Choi SH; Lü J; Kim SH
Biol Pharm Bull; 2010; 33(11):1828-34. PubMed ID: 21048307
[TBL] [Abstract][Full Text] [Related]
12. Tanshinone IIA induces cell death via Beclin-1-dependent autophagy in oral squamous cell carcinoma SCC-9 cell line.
Qiu Y; Li C; Wang Q; Zeng X; Ji P
Cancer Med; 2018 Feb; 7(2):397-407. PubMed ID: 29316373
[TBL] [Abstract][Full Text] [Related]
13. Sodium tanshinone IIA sulfonate: A review of pharmacological activity and pharmacokinetics.
Zhou ZY; Zhao WR; Zhang J; Chen XL; Tang JY
Biomed Pharmacother; 2019 Oct; 118():109362. PubMed ID: 31545252
[TBL] [Abstract][Full Text] [Related]
14. Tanshinone IIA alleviates acute ethanol-induced myocardial apoptosis mainly through inhibiting the expression of PDCD4 and activating the PI3K/Akt pathway.
Deng H; Yu B; Li Y
Phytother Res; 2021 Aug; 35(8):4309-4323. PubMed ID: 34169595
[TBL] [Abstract][Full Text] [Related]
15. Tanshinone IIA Suppresses Proliferation and Inflammatory Cytokine Production of Synovial Fibroblasts from Rheumatoid Arthritis Patients Induced by TNF-α and Attenuates the Inflammatory Response in AIA Mice.
Du H; Wang Y; Zeng Y; Huang X; Liu D; Ye L; Li Y; Chen X; Liu T; Li H; Wu J; Yu Q; Wu Y; Jie L
Front Pharmacol; 2020; 11():568. PubMed ID: 32499694
[TBL] [Abstract][Full Text] [Related]
16. Prospective therapeutic potential of Tanshinone IIA: An updated overview.
Ansari MA; Khan FB; Safdari HA; Almatroudi A; Alzohairy MA; Safdari M; Amirizadeh M; Rehman S; Equbal MJ; Hoque M
Pharmacol Res; 2021 Feb; 164():105364. PubMed ID: 33285229
[TBL] [Abstract][Full Text] [Related]
17. The anticancer mechanism investigation of Tanshinone II
Cao YF; Wang SF; Li X; Zhang YL; Qiao YJ
BMC Syst Biol; 2018 Oct; 12(1):90. PubMed ID: 30373594
[TBL] [Abstract][Full Text] [Related]
18. Tanshinone IIA: A Review of its Anticancer Effects.
Fang ZY; Zhang M; Liu JN; Zhao X; Zhang YQ; Fang L
Front Pharmacol; 2020; 11():611087. PubMed ID: 33597880
[TBL] [Abstract][Full Text] [Related]
19. Tanshinone IIA induces apoptosis and autophagy in acute monocytic leukemia via downregulation of PI3K/Akt pathway.
Zhang Y; Geng Y; He J; Wu D; Zhang T; Xue L; Zhang L; He A
Am J Transl Res; 2019; 11(5):2995-3006. PubMed ID: 31217869
[TBL] [Abstract][Full Text] [Related]
20. Tanshinone IIA promotes the proliferation and differentiation ability of primary muscle stem cells via MAPK and Akt signaling.
Liu W; Wang T; Wang W; Lin X; Xie K
Biochem Biophys Res Commun; 2023 Dec; 689():149235. PubMed ID: 37976834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
